Rui Wang1, Stephen W Lagakos. 1. Biostatistics Center, Massachusetts General Hospital, Boston, MA, USA. rwang@hsph.harvard.edu
Abstract
OBJECTIVE: To elucidate when and how cross-sectional estimators of HIV incidence rates based on a sensitive and less sensitive diagnostic test should be adjusted. METHODS: Evaluate the statistical properties of unadjusted and adjusted cross-sectional estimators of HIV incidence, including the adjusted estimators considered by McDougal et al, for the 2 settings where (a) all infected subjects eventually become reactive to the less sensitive test, and (b) a subset of infected subjects indefinitely remain nonreactive to the less sensitive test. Derive the maximum likelihood estimator of incidence for the latter setting and use analytical results and simulation studies to compare the performance of the various estimators. RESULTS: When every infected subject would eventually become reactive to the less sensitive test, the McDougal adjusted estimator is uniformly less precise than the unadjusted estimator and more susceptible to bias. When a subset of the infected population would indefinitely remain nonreactive to the less sensitive test, the McDougal adjusted estimator is less precise than the maximum likelihood estimator, which coincides with an estimator developed by McWalter and Welte using a mathematical modeling approach. When the assumed model is incorrect, the unadjusted estimator overestimates incidence, whereas the maximum likelihood estimator can be biased in either direction. CONCLUSIONS: The standard unadjusted cross-sectional estimator of HIV incidence should be used when all infected individuals would eventually become reactive to the less sensitive test. When a subset of individuals would indefinitely remain nonreactive to the less sensitive test, the maximum likelihood estimator for this setting should be used. Characterizing the proportion of individuals who would indefinitely remain nonreactive is crucial for accurate estimation of HIV incidence.
OBJECTIVE: To elucidate when and how cross-sectional estimators of HIV incidence rates based on a sensitive and less sensitive diagnostic test should be adjusted. METHODS: Evaluate the statistical properties of unadjusted and adjusted cross-sectional estimators of HIV incidence, including the adjusted estimators considered by McDougal et al, for the 2 settings where (a) all infected subjects eventually become reactive to the less sensitive test, and (b) a subset of infected subjects indefinitely remain nonreactive to the less sensitive test. Derive the maximum likelihood estimator of incidence for the latter setting and use analytical results and simulation studies to compare the performance of the various estimators. RESULTS: When every infected subject would eventually become reactive to the less sensitive test, the McDougal adjusted estimator is uniformly less precise than the unadjusted estimator and more susceptible to bias. When a subset of the infected population would indefinitely remain nonreactive to the less sensitive test, the McDougal adjusted estimator is less precise than the maximum likelihood estimator, which coincides with an estimator developed by McWalter and Welte using a mathematical modeling approach. When the assumed model is incorrect, the unadjusted estimator overestimates incidence, whereas the maximum likelihood estimator can be biased in either direction. CONCLUSIONS: The standard unadjusted cross-sectional estimator of HIV incidence should be used when all infected individuals would eventually become reactive to the less sensitive test. When a subset of individuals would indefinitely remain nonreactive to the less sensitive test, the maximum likelihood estimator for this setting should be used. Characterizing the proportion of individuals who would indefinitely remain nonreactive is crucial for accurate estimation of HIV incidence.
Authors: John W Hargrove; Jean H Humphrey; Kuda Mutasa; Bharat S Parekh; J Steve McDougal; Robert Ntozini; Henry Chidawanyika; Lawrence H Moulton; Brian Ward; Kusum Nathoo; Peter J Iliff; Ekkehard Kopp Journal: AIDS Date: 2008-02-19 Impact factor: 4.177
Authors: J Steven McDougal; Bharat S Parekh; Michael L Peterson; Bernard M Branson; Trudy Dobbs; Marta Ackers; Marc Gurwith Journal: AIDS Res Hum Retroviruses Date: 2006-10 Impact factor: 2.205
Authors: Bharat S Parekh; M Susan Kennedy; Trudy Dobbs; Chou-Pong Pau; Robert Byers; Timothy Green; Dale J Hu; Suphak Vanichseni; Nancy L Young; Kachit Choopanya; Timothy D Mastro; J Steven McDougal Journal: AIDS Res Hum Retroviruses Date: 2002-03-01 Impact factor: 2.205
Authors: Niel T Constantine; Anne M Sill; Noreen Jack; Kristen Kreisel; Jeffrey Edwards; Thomas Cafarella; Harry Smith; Courtenay Bartholomew; Farley R Cleghorn; William A Blattner Journal: J Acquir Immune Defic Syndr Date: 2003-01-01 Impact factor: 3.731
Authors: R S Janssen; G A Satten; S L Stramer; B D Rawal; T R O'Brien; B J Weiblen; F M Hecht; N Jack; F R Cleghorn; J O Kahn; M A Chesney; M P Busch Journal: JAMA Date: 1998-07-01 Impact factor: 56.272
Authors: Etienne Karita; Matt Price; Eric Hunter; Elwyn Chomba; Susan Allen; Lin Fei; Anatoli Kamali; Eduard J Sanders; Omu Anzala; Michael Katende; Nzeera Ketter Journal: AIDS Date: 2007-02-19 Impact factor: 4.177
Authors: Till Bärnighausen; Claudia Wallrauch; Alex Welte; Thomas A McWalter; Nhlanhla Mbizana; Johannes Viljoen; Natalie Graham; Frank Tanser; Adrian Puren; Marie-Louise Newell Journal: PLoS One Date: 2008-11-04 Impact factor: 3.240
Authors: Rui Wang; Jia Weng; Sikhulile Moyo; Debanjan Pain; Christopher D Barr; Dorcas Maruapula; Dineo Mongwato; Joseph Makhema; Vladimir Novitsky; M Essex Journal: AIDS Res Hum Retroviruses Date: 2013-04-19 Impact factor: 2.205
Authors: Oliver Laeyendecker; Ron Brookmeyer; Matthew M Cousins; Caroline E Mullis; Jacob Konikoff; Deborah Donnell; Connie Celum; Susan P Buchbinder; George R Seage; Gregory D Kirk; Shruti H Mehta; Jacquie Astemborski; Lisa P Jacobson; Joseph B Margolick; Joelle Brown; Thomas C Quinn; Susan H Eshleman Journal: J Infect Dis Date: 2012-11-05 Impact factor: 5.226
Authors: Sikhulile Moyo; Tessa LeCuyer; Rui Wang; Simani Gaseitsiwe; Jia Weng; Rosemary Musonda; Hermann Bussmann; Madisa Mine; Susan Engelbrecht; Joseph Makhema; Richard Marlink; Marianna K Baum; Vladimir Novitsky; M Essex Journal: AIDS Res Hum Retroviruses Date: 2013-09-06 Impact factor: 2.205
Authors: G Murphy; C D Pilcher; S M Keating; R Kassanjee; S N Facente; A Welte; E Grebe; K Marson; M P Busch; P Dailey; N Parkin; J Osborn; S Ongarello; K Marsh; J M Garcia-Calleja Journal: Epidemiol Infect Date: 2016-12-22 Impact factor: 4.434